Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine L Lev

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|December 25, 2019
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic CombinationsTaylor Morrisette, Razieh Kebriaei, Katherine L Lev, et al.
Infectious Diseases and Therapy|October 5, 2023
Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of DaptomycinRazieh Kebriaei, Jacinda C Abdul-Mutakabbir, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic ModelRazieh Kebriaei, Katherine L Lev, Kyle C Stamper, et al.
Journal of Applied Microbiology|June 2, 2022
Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testingDana J Holger, Katherine L Lev, Razieh Kebriaei, et al.
Antibiotics (Basel, Switzerland)|October 17, 2020
Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic ModelJacinda C Abdul-Mutakabbir, Razieh Kebriaei, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2021
Exebacase in Addition to Daptomycin against MRSARazieh Kebriaei, Kyle C Stamper, Katherine L Lev, et al.
Environmental Toxicology|January 10, 2026
Cyanopeptide Mixtures Induce Variable Synergistic and Antagonistic Effects Across Diverse Human Cell LinesLauren N Hart, Katherine L Lev, Sierra Hefferan, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2023
Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic Biofilm ModelTaylor Morrisette, Kyle C Stamper, Katherine L Lev, et al.
Microbiology Spectrum|March 29, 2022
Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections <i>In Vitro</i>: Bacteriophage-Antibiotic CombinationRazieh Kebriaei, Katherine L Lev, Rahi M Shah, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2021
Evaluation of Bacteriophage Cocktails Alone and in Combination with Daptomycin against Daptomycin-Nonsusceptible Enterococcus faeciumTaylor Morrisette, Katherine L Lev, Gregory S Canfield, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|December 25, 2019
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic CombinationsTaylor Morrisette, Razieh Kebriaei, Katherine L Lev, et al.
Infectious Diseases and Therapy|October 5, 2023
Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of DaptomycinRazieh Kebriaei, Jacinda C Abdul-Mutakabbir, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic ModelRazieh Kebriaei, Katherine L Lev, Kyle C Stamper, et al.
Journal of Applied Microbiology|June 2, 2022
Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testingDana J Holger, Katherine L Lev, Razieh Kebriaei, et al.
Antibiotics (Basel, Switzerland)|October 17, 2020
Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic ModelJacinda C Abdul-Mutakabbir, Razieh Kebriaei, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2021
Exebacase in Addition to Daptomycin against MRSARazieh Kebriaei, Kyle C Stamper, Katherine L Lev, et al.
Environmental Toxicology|January 10, 2026
Cyanopeptide Mixtures Induce Variable Synergistic and Antagonistic Effects Across Diverse Human Cell LinesLauren N Hart, Katherine L Lev, Sierra Hefferan, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2023
Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic Biofilm ModelTaylor Morrisette, Kyle C Stamper, Katherine L Lev, et al.
Microbiology Spectrum|March 29, 2022
Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections <i>In Vitro</i>: Bacteriophage-Antibiotic CombinationRazieh Kebriaei, Katherine L Lev, Rahi M Shah, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2021
Evaluation of Bacteriophage Cocktails Alone and in Combination with Daptomycin against Daptomycin-Nonsusceptible Enterococcus faeciumTaylor Morrisette, Katherine L Lev, Gregory S Canfield, et al.
Pageof 2